PMC:7405836 / 104544-104727 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T937","span":{"begin":126,"end":130},"obj":"Disease"}],"attributes":[{"id":"A937","pred":"mondo_id","subj":"T937","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"These two protease inhibitors (lopinavir and ritonavir), in combination with ribavirin, gave encouraging clinical outcomes in SARS patients, suggesting their therapeutic values (165)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T58724","span":{"begin":10,"end":29},"obj":"Chemical"},{"id":"T76137","span":{"begin":19,"end":29},"obj":"Chemical"},{"id":"T78377","span":{"begin":31,"end":54},"obj":"Chemical"},{"id":"T500","span":{"begin":31,"end":40},"obj":"Chemical"},{"id":"T88215","span":{"begin":45,"end":54},"obj":"Chemical"},{"id":"T10275","span":{"begin":77,"end":86},"obj":"Chemical"}],"attributes":[{"id":"A88850","pred":"chebi_id","subj":"T58724","obj":"http://purl.obolibrary.org/obo/CHEBI_37670"},{"id":"A43895","pred":"chebi_id","subj":"T58724","obj":"http://purl.obolibrary.org/obo/CHEBI_60258"},{"id":"A9752","pred":"chebi_id","subj":"T76137","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A49838","pred":"chebi_id","subj":"T78377","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A58528","pred":"chebi_id","subj":"T500","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A15379","pred":"chebi_id","subj":"T88215","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A88287","pred":"chebi_id","subj":"T10275","obj":"http://purl.obolibrary.org/obo/CHEBI_63580"}],"text":"These two protease inhibitors (lopinavir and ritonavir), in combination with ribavirin, gave encouraging clinical outcomes in SARS patients, suggesting their therapeutic values (165)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T719","span":{"begin":0,"end":183},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"These two protease inhibitors (lopinavir and ritonavir), in combination with ribavirin, gave encouraging clinical outcomes in SARS patients, suggesting their therapeutic values (165)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2799","span":{"begin":131,"end":139},"obj":"Species"},{"id":"2809","span":{"begin":31,"end":40},"obj":"Chemical"},{"id":"2810","span":{"begin":77,"end":86},"obj":"Chemical"}],"attributes":[{"id":"A2799","pred":"tao:has_database_id","subj":"2799","obj":"Tax:9606"},{"id":"A2809","pred":"tao:has_database_id","subj":"2809","obj":"MESH:D061466"},{"id":"A2810","pred":"tao:has_database_id","subj":"2810","obj":"MESH:D012254"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"These two protease inhibitors (lopinavir and ritonavir), in combination with ribavirin, gave encouraging clinical outcomes in SARS patients, suggesting their therapeutic values (165)."}